Search Results

Astragaloside IV regulates FOXM1 deubiquitination to ameliorate trophoblast damage caused by high glucose.

• Authors : Li F; Department of Obstetrics and Gynecology, Ankang People's Hospital, No.38 Jiangbei Avenve, Hanbin District, Ankang, 725000, China.; Zhao X

Subjects: Saponins*/Saponins*/Saponins*/pharmacology ; Trophoblasts*/Trophoblasts*/Trophoblasts*/drug effects ; Trophoblasts*/Trophoblasts*/Trophoblasts*/metabolism

• Source: Hereditas [Hereditas] 2025 Jun 13; Vol. 162 (1), pp. 104. Date of Electronic Publication: 2025 Jun 13.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 0374654 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

The deubiquitinase OTUD3 plays a neuroprotective role by reducing ferroptosis induced by cerebral ischaemia reperfusion via stabilizing PLK1 via deubiquitination.

• Authors : Cheng J; Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.; Tian Q

Subjects: Proto-Oncogene Proteins*/Proto-Oncogene Proteins*/Proto-Oncogene Proteins*/metabolism ; Proto-Oncogene Proteins*/Proto-Oncogene Proteins*/Proto-Oncogene Proteins*/genetics ; Protein Serine-Threonine Kinases*/Protein Serine-Threonine Kinases*/Protein Serine-Threonine Kinases*/metabolism

• Source: Clinical and translational medicine [Clin Transl Med] 2025 May; Vol. 15 (5), pp. e70347.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet ISSN: 2001-1326

Record details

Cardiomyocyte-Enriched USP20 Ameliorates Pathological Cardiac Hypertrophy by Targeting STAT3 Deubiquitination.

• Authors : Zhong L; Department of Cardiology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.; State Key Laboratory of Transvascular Implantation Devices, Hangzhou, 310009, China.

Subjects: STAT3 Transcription Factor*/STAT3 Transcription Factor*/STAT3 Transcription Factor*/metabolism ; STAT3 Transcription Factor*/STAT3 Transcription Factor*/STAT3 Transcription Factor*/genetics ; Myocytes, Cardiac*/Myocytes, Cardiac*/Myocytes, Cardiac*/metabolism

• Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2025 Jun; Vol. 12 (23), pp. e2416478. Date of Electronic Publication: 2025 Apr 07.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

Insights into the potential role of BMSCs-exo delivered USP14 on SIRT1 deubiquitination in Staphylococcus aureus-induced model of osteomyelitis.

• Authors : Yu J; Orthopaedic Trauma Department, General Hospital of Ningxia Medical University, 804 Shengli South Street, Xingqing District, Yinchuan City, Ningxia, 750001, China.; Yang M

Subjects: Sirtuin 1*/Sirtuin 1*/Sirtuin 1*/metabolism ; Ubiquitin Thiolesterase*/Ubiquitin Thiolesterase*/Ubiquitin Thiolesterase*/metabolism ; Ubiquitin Thiolesterase*/Ubiquitin Thiolesterase*/Ubiquitin Thiolesterase*/genetics

• Source: Journal of orthopaedic surgery and research [J Orthop Surg Res] 2025 May 29; Vol. 20 (1), pp. 539. Date of Electronic Publication: 2025 May 29.Publisher: BioMed Central Country of Publication: England NLM ID: 101265112 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-799X

Record details

NAP1L1 degradation by FBXW7 reduces the deubiquitination of HDGF-p62 signaling to stimulate autophagy and induce primary cisplatin chemosensitivity in nasopharyngeal carcinoma.

• Authors : Gong B; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.; Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.

Subjects: Cisplatin*/Cisplatin*/Cisplatin*/pharmacology ; Nasopharyngeal Carcinoma*/Nasopharyngeal Carcinoma*/Nasopharyngeal Carcinoma*/metabolism ; Nasopharyngeal Carcinoma*/Nasopharyngeal Carcinoma*/Nasopharyngeal Carcinoma*/drug therapy

• Source: Molecular cancer [Mol Cancer] 2025 May 26; Vol. 24 (1), pp. 152. Date of Electronic Publication: 2025 May 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

Record details

Deubiquitination of DNM1L by USP3 triggers the development and metastasis of gallbladder carcinoma.

• Authors : Liang R; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhang X

Subjects: Gallbladder Neoplasms*/Gallbladder Neoplasms*/Gallbladder Neoplasms*/pathology ; Gallbladder Neoplasms*/Gallbladder Neoplasms*/Gallbladder Neoplasms*/metabolism ; Gallbladder Neoplasms*/Gallbladder Neoplasms*/Gallbladder Neoplasms*/genetics

• Source: Biology direct [Biol Direct] 2025 Apr 07; Vol. 20 (1), pp. 47. Date of Electronic Publication: 2025 Apr 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101258412 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6150

Record details

SPICE1 promotes osteosarcoma growth by enhancing the deubiquitination of FASN mediated by USP10.

• Authors : Tong W; Department of Orthopedic Surgery, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.; Jiangxi Provincial Key Laboratory of Spine and Spinal Cord Diseases, Nanchang, 330006, People's Republic of China.

Subjects: Ubiquitin Thiolesterase*/Ubiquitin Thiolesterase*/Ubiquitin Thiolesterase*/metabolism ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/pathology ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/metabolism

• Source: Journal of translational medicine [J Transl Med] 2025 Feb 21; Vol. 23 (1), pp. 220. Date of Electronic Publication: 2025 Feb 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

Ubiquitin-specific peptidase 14 promotes neuron injury by stabilizing acyl-CoA synthetase long-chain family member 4 through deubiquitination.

• Authors : Hao X; Department of Teaching Administration, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, China.; Department of Pharmacy, Graduate School and Faculty of Open Learning, Cavite State University, Indang, Philippines.

• Source: CytoJournal [Cytojournal] 2025 Feb 05; Vol. 22, pp. 11. Date of Electronic Publication: 2025 Feb 05 (Print Publication: 2025).Publisher: Scientific Scholar on behalf of Cytopathology Foundation Country of Publication: United States NLM ID: 101231642 Publication Model: eCollection

Record details

HOXA5 Derives the Malignant Progression and Cisplatin Resistance of Esophageal Squamous Cell Carcinoma by Regulating USP18-Mediated IFI27 Deubiquitination.

• Authors : Wang Q; Department of Thoracic Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; Ren S

Subjects: Cisplatin*/Cisplatin*/Cisplatin*/pharmacology ; Cisplatin*/Cisplatin*/Cisplatin*/therapeutic use ; Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/pathology

• Source: Thoracic cancer [Thorac Cancer] 2025 Feb; Vol. 16 (4), pp. e70013.Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print Cited Medium: Internet ISSN:

Record details

USP2-induced upregulation of LEF1 through deubiquitination relieves osteoporosis development by promoting the osteogenic differentiation of bone marrow mesenchymal stem cells.

• Authors : Zhang Z; Department of Orthopedics Ward 2, Kailuan General Hospital, No. 57, Xinhua East Road, Tangshan City, Hebei Province, 063000, China.; Cao J

Subjects: Mesenchymal Stem Cells*/Mesenchymal Stem Cells*/Mesenchymal Stem Cells*/metabolism ; Osteogenesis*/Osteogenesis*/Osteogenesis*/physiology ; Osteogenesis*/Osteogenesis*/Osteogenesis*/genetics

• Source: Journal of orthopaedic surgery and research [J Orthop Surg Res] 2025 Apr 29; Vol. 20 (1), pp. 430. Date of Electronic Publication: 2025 Apr 29.Publisher: BioMed Central Country of Publication: England NLM ID: 101265112 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-799X

Record details